Cover Image




INTRODUCTION - Chronic Renal Failure is a            progressive decline of the glomerular filtration rate, leading to an increase of serum creatinine and blood urea nitrogen levels. Frequent sampling of blood is mandatory to diagnose and  monitor the progression of the disease. Collection of blood for serum analysis is an invasive procedure which often causes discomfort and anxiety to the patients. Saliva, a multi-constituent biologic fluid secreted by the salivary glands, is the major          contributor of oral health. This study was done to determine the diagnostic ability of saliva as an alternative to serum to estimate creatinine in CKD patients. AIM OF THE STUDY - 1.To estimate

serum and salivary creatinine levels among patients with Chronic Kidney Disease 2.To compare and correlate the serum and salivary creatinine levels among CKD cases and to evaluate the role of saliva as a noninvasive alternative to serum for creatinine estimation in CKD patients. MATERIALS AND  METHODS - This case-control study was done by selecting 50 patients with Chronic Kidney Disease (CKD) and 50 age and sex-matched healthy controls. GFR was estimated by   Cockcroft-Gault formula. Blood and whole unstimulated saliva samples were simultaneously obtained from all the patients. The samples were assayed immediately using creatinine estimation kit by Jaffe kinetic reaction. Statistical analysis was done using t-test. Correlation between serum and salivary creatinine was obtained in cases and controls using Pearsons correlation.  RESULTS - Serum as well as salivary creatinine levels were found to be significantly higher in CKD patients than controls   (p value less than 0.001).The correlation between serum and salivary creatinine in controls was not found to be significant, Pearson correlation coefficient, 0.168, whereas in CKD patients a significant positive correlation was found, 0.952.   CONCLUSION - Saliva can be used as a non-invasive    diagnostic tool as an alternative to serum, for estimating creatinine among Chronic Kidney Disease patients.


Full Text:



C.Seethalakshmi, D.Koteeswaran, V.Chiranjeevi,“Correlation of Serum and Salivary Biochemical Parameters in end Stage Renal Disease Patients Undergoing Hemodialysis in Pre and Post-Dialysis State”. Journal of Clinical and Diagnostic Research. 2014 Dec, Vol-8(12): CC12-CC14

S. Levey, K.-U. Eckardt, Y. Tsukamoto et al., “Definition and classification of chronic kidney disease: a position statement from KidneyDisease: Improving Global Outcomes (KDIGO)z,” Kidney International, vol. 67, no. 6, pp. 2089–2100, 2005.

A. C. Guyton and J. E. Hall, “The body fluids and kidneys,” in Textbook of Medical Physiology, pp. 291–415, Elsevier Saunders, 11th edition, 2006.

S. Arun,M. V. Prabhu, K. N. Chowta, and M. L. Bengre, “The haematological pattern of the patients with chronic kidney disease in a tertiary care setup in south India,” Journal of Clinicaland Diagnostic Research, vol. 6, pp. 1003–1006, 2012.

G. Bayraktar, I. Kurtulus, R. Kazancioglu et al., “Oral health and inflammation in patients with end-stage renal failure,” Peritoneal Dialysis International, vol. 29, no. 4, pp. 472–479, 2009.

E. Kaufman and I. B. Lamster, “The diagnostic applications of saliva—a review,” Critical Reviews in Oral Biology & Medicine, vol. 13, no. 2, pp. 197–212, 2002.

Y.-H. Lee andD. T.Wong, “Saliva: an emerging biofluid for early detection of diseases,” American Journal ofDentistry, vol. 22,no.4, pp. 241–248, 2009.

R. M. Nagler, “Saliva analysis formonitoring dialysis and renal function,” Clinical Chemistry, vol. 54, no. 9, pp. 1415–1417, 2008.

L. R. Bigler, C. F. Streckfus, andW. P. Dubinsky, “Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity,” Clinics in LaboratoryMedicine, vol. 29, no.1, pp. 71–85, 2009.

Amato AA, Santos GM.Neves F. Thyroid hormone action in chronic kidney disease. Current opinion in endocrinology, Diabetes and Obesity. 2008; 15:459-465.

Tangri N, Stevens LA, Griffith J. A predictive model for progression of chronic kidney disease to kidney failure. JAMA,2011;305(15):1553-9.

KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis.2002.

T. Pfaffe, J. Cooper-White, P. Beyerlein, K. Kostner, and C. Punyadeera, “Diagnostic potential of saliva: current state and future applications,” Clinical Chemistry, vol. 57, no. 5, pp. 675–687, 2011.

M. Gr¨oschl, “Current status of salivary hormone analysis,” Clinical Chemistry, vol. 54, no. 11, pp. 1759–1769, 2008.

C. Streckfus and L. Bigler, “The use of soluble, salivary c-erbB-2 for the detection and postoperative follow-up of breast cancer inwomen: the results of a five-year translational research study, ”Advances in Dental Research, vol. 18, no. 1, pp. 17–24, 2005.

Edmund J. Lamb, Christopher P. Price, “Kidney function tests”. Carl A. Burtis, Edward R. Ashwood, David E. Bruns, “Tietz textbook of clinical chemistry and molecular diagnostics”, fifth edition, Saunders Elsevier, pp. 669-707.

N. Jenkins, Physiology and Biochemistry of theMouth, Blackwell, 4th edition, 1978

Y. Xia, C. Peng, Z. Zhou et al., “Clinical significance of saliva urea, creatinine, and uric acid levels in patients with chronic kidney disease,” Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol. 37, no. 11, pp. 1171–1176, 2012.

Ramesh Venkatapathy,Vasupradha Govindarajan, Nirima Oza, Sreejith Parameswaran, Balamurali Pennagaram Dhanasekaran, and Karthikshree V. Prashad, “Salivary Creatinine Estimation as an Alternative to Serum Creatinine in Chronic Kidney Disease Patients”, International Journal of Nephrology Volume 2014, Article ID 742724.

W. L. Chiou and F. S. Pu, “Creatinine. VIII: saliva levels of endogenous ’true’ creatinine in normal subjects,” Clinical Pharmacology andTherapeutics, vol. 25, no. 6, pp. 777–782, 1979.

K. Ivanovski, V. Naumovski, M. Kostadinova, S. Pesevska, K. Drijanska, and V. Filipce, “Xerostomia and salivary levels of glucose and urea in patients with diabetes,” Prilozi, vol. 33, no.2, pp. 219–229, 2012.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University